The DCC protein and colon cancer.

The use of early and midpoint adenoma-carcinoma sequence biomarkers in prediction of neoplastic progression in patients with a history of colorectal neoplasia. Dig Dis Sci (2006) 0.75

The DCC protein and prognosis in colorectal cancer. N Engl J Med (1996) 3.51

Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol (2000) 1.63

Successful treatment of hepatitis C in sickle-cell disease. Ann Intern Med (2000) 0.88

Inflammatory cells degrade inter-alpha inhibitor to liberate urinary proteinase inhibitors. J Leukoc Biol (1989) 0.83

Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br J Haematol (1994) 0.81

cis-dichlorodiammineplatinum (II) as a selective modifier of the oxidation-sensitive reactive-center methionine in alpha 1-antitrypsin. J Biol Chem (1988) 0.80

Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin. Breast Cancer Res Treat (1995) 0.77

Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. J Inorg Biochem (1988) 0.75

Reversible nefazodone-induced liver failure. Dig Dis Sci (2000) 0.75

Primary central nervous system lymphoma, presenting as diabetes insipidus, as a sequela of hepatitis C. Am J Med (1999) 0.75

The view from the bed. N C Med J (1987) 0.75

Teaching the context of doctoring. Acad Med (1997) 0.75